Tracking the SARS-CoV-2 virus with genome sequencing
S&P 500 (INDEXSP: .INX) falls from overbought to neutral
Patient In AstraZeneca COVID-19 Vaccine Trial Dies
Observed COVID-19 variability may have underlying molecular sources
MBA forecast for 2021: Prepare for rising mortgage interest rates
Spain Becomes Sixth Country To Top 1 Million COVID-19 Cases: Live Updates
GlaxoSmithKline's vaccines group aims for a first as it kicks off PhIII RSV studies
Telia Inks 5G Network Deals With Ericsson, Nokia
Engines Not Yet in Sync: A Multispeed Recovery in Asia
BD’s Covid-19-Flu Combo Test Wins European Clearance
AZ’s COVID-19 vaccine trial ready to resume in US – reports
Opko Health Rolls Out Multiplex COVID-19, Influenza A/B Test
Peak Optimism? S&P Futures Hit After Too Much "Stimulus Optimism" Sends 10Y Yields Surging
Chinese City Launches Emergency COVID-19 Vaccine Program; India Outbreak Continues To Slow: Live Updates
Xeris Wins FDA Fast Track Path For Epilepsy Treatment; Shares Spike 9%
First Tests Of New "Immunity Passports" Will Take Place Wednesday
Why cruise lines could be worth buying again
US Dollar Erases Gains As Nancy Pelosi Says Stimulus Deal Possible by Day’s End
Great Barrington Declaration and What It Says About Us
California will independently review coronavirus vaccines
Pfizer, BioNTech start combined trials of Covid-19 vaccine candidate in Japan
U.S. FDA meeting on Covid-19 vaccines to discuss criteria for emergency nod
Ireland Imposes New Fines For Violating Europe's Most Restrictive Lockdown: Live Updates
Moderna CEO expects Covid-19 vaccine interim results in November – WSJ
India Reports Fewest COVID-19 Cases In 3 Months; Argentina 5th Country To Top 5 Million Cases: Live Updates
Is reaching zero COVID-19 possible?
Futures Rebound On Stimulus Optimism Ahead Of "Do Or Die" Deadline
UK government signs contract for COVID-19 challenge trial
Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approved
Kamada To Supply Plasma-Based Covid-19 Therapy To Israel; Shares Surge 6%